Timothy M. Acker,Dennis C. Liotta,Stephen F. Traynelis,Yao Jing
申请号:
US16053265
公开号:
US20180346445A1
申请日:
2018.08.02
申请国别(地区):
US
年份:
2018
代理人:
摘要:
This disclosure relates to pyrazoline dihydroquinolone derivatives, pharmaceutical compositions, and uses. In certain embodiments, the compounds are selective NMDA receptor inhibitors and are useful in therapeutic methods related thereto. In certain embodiments, this disclosure relates to pharmaceutical compositions comprising a compound of the following formula:or salts, esters, or prodrugs thereof, as provided herein.